- ICH GCP
- Rejestr badań klinicznych UE
Najnowsze wersje próbne
EudraCT Number: 2004-000806-39 | Sponsor Protocol Number: CECOG/BREAST.2.2.005 | Start Date: 2005-02-10 | |||||||||||
Sponsor Name: CECOG | |||||||||||||
Full Title: Randomized Phase II Study of Dose-Dense Fluorouracil Plus Epirubicin75 Plus Cyclophosphamide (FEC75) and Fluorouracil Plus Epirubicin90 Plus Cyclophosphamide (FEC90) as Adjuvant Therapy for Early B... | |||||||||||||
Medical condition: Early Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000023-15 | Sponsor Protocol Number: H7T-MC-TAAL | Start Date: 2005-02-10 | |||||||||||
Sponsor Name: Eli Lilly and Company Limited | |||||||||||||
Full Title: A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention | |||||||||||||
Medical condition: Reduction of atherothrombotic events in patients with acute coronary syndromes (ACS) that is patients with ST-segment elevation MI [STEMI], non-ST-segment elevation MI [NSTEMI], or unstable angina... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) AT (Completed) FI (Completed) HU (Completed) CZ (Completed) SK (Completed) DE (Completed) IT (Completed) LT (Completed) EE (Completed) LV (Completed) IS (Completed) ES (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000655-41 | Sponsor Protocol Number: CFTY720A2308 | Start Date: 2005-02-10 | |||||||||||
Sponsor Name: Novartis Farmacéutica S.A | |||||||||||||
Full Title: A one-year, multicenter, open-label, feasibility study to evaluate the safety and the efficacy of FTY720 5mg introduction and CNI elimination in adult maintenance renal transplant reicpients mainta... | |||||||||||||
Medical condition: prevention of acute rejection in maintenance renal transplant recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004727-36 | Sponsor Protocol Number: NR 8230-3/2004 | Start Date: 2005-02-10 | ||||||
Sponsor Name: Charles University, 3rd Faculty of Medicine | ||||||||
Full Title: Influence of low-dose i.v. growth hormone treatment together with glutamine supplementation in late-phase critically ill patient after multiple injury. A pilot study. | ||||||||
Medical condition: Prolonged phase of critical illness after severe multiple trauma | ||||||||
|
||||||||
Population Age: Adults | Gender: Female | |||||||
Trial protocol: CZ (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003820-37 | Sponsor Protocol Number: IGIT-008 | Start Date: 2005-02-10 | |||||||||||
Sponsor Name: Bracco Imaging Spa | |||||||||||||
Full Title: A multicentre study to evaluate the Contibution of SonoVue® and CnTI technology (Contrast Tuned Imaging) to a correct classification of Adnexal Masses as benign or malignant | |||||||||||||
Medical condition: COMPLEX ADNEXAL MASS IN PELVIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005095-17 | Sponsor Protocol Number: EA041999 | Start Date: 2005-02-10 | ||||||
Sponsor Name: Engelhard Arzneimittel GmbH & Co. KG | ||||||||
Full Title: Randomised, double-blind, placebo-controlled, monocentric phase III study on the efficacy and safety of Lidocaine 8 mg Sore Throat Lozenges in patients with moderate to severe acute sore throat not... | ||||||||
Medical condition: The study will be performed in patients suffering from acute sore throat not necessarily to be treated with antibiotics | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003000-37 | Sponsor Protocol Number: 0653A-807 | Start Date: 2005-02-09 | |||||||||||
Sponsor Name: Merck & Co., Inc. | |||||||||||||
Full Title: A Double-Blind, Multicenter Study to Assess the LDL-C Lowering of Combination tablets Ezetimibe/Simvastatin (10mg/20mg) and Ezetimibe/Simvastatin (10mg/40mg) compared to Atorvastatin 20mg in Patien... | |||||||||||||
Medical condition: Hypercholesterolemia in patients with Type II Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) DE (Completed) BE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002172-42 | Sponsor Protocol Number: Bay 38-9456/11336 | Start Date: 2005-02-09 | |||||||||||
Sponsor Name: Bayer Oy | |||||||||||||
Full Title: A randomized, double-blind, double-dummy, multi-center, parallel group study to compare the tolerability and efficacy of once daily vardenafil versus vardenafil PRN versus placebo in men immediatel... | |||||||||||||
Medical condition: Erektiohäiriö | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) SE (Completed) DE (Completed) AT (Completed) GB (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-005103-16 | Sponsor Protocol Number: ETF 5450 | Start Date: 2005-02-09 | ||||||
Sponsor Name: Estonian Science Foundation | ||||||||
Full Title: Central serotonergic activity measured by citalopram challenge test and platelet monoamine oxidase activity, associations with gene polymorphism (5-HTTLPR) and impulsivity | ||||||||
Medical condition: Healthy volunteers | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: EE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004974-94 | Sponsor Protocol Number: 74460 | Start Date: 2005-02-09 | ||||||
Sponsor Name: Santen Oy | ||||||||
Full Title: Efficacy and safety of tafluprost 0.0015% eye drops as adjunctive therapy with timolol 0.5% eye drops. A randomised, placebo-controlled, phase III study in patients with open-angle glaucoma or ocul... | ||||||||
Medical condition: Open angle glaucoma or ocular hypertension | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: EE (Completed) LV (Completed) | ||||||||
Trial results: View results |